3.91
price down icon6.68%   -0.28
after-market アフターアワーズ: 3.85 -0.06 -1.53%
loading
前日終値:
$4.19
開ける:
$4.17
24時間の取引高:
1.95M
Relative Volume:
0.76
時価総額:
$426.95M
収益:
-
当期純損益:
$-209.38M
株価収益率:
-2.0833
EPS:
-1.8768
ネットキャッシュフロー:
$-179.81M
1週間 パフォーマンス:
+1.82%
1か月 パフォーマンス:
+50.38%
6か月 パフォーマンス:
+4.83%
1年 パフォーマンス:
+23.73%
1日の値動き範囲:
Value
$3.77
$4.17
1週間の範囲:
Value
$3.77
$4.33
52週間の値動き範囲:
Value
$2.53
$5.45

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
名前
Rocket Pharmaceuticals Inc
Name
セクター
Healthcare (1096)
Name
電話
646-440-9100
Name
住所
350 FIFTH AVENUE, NEW YORK, NY
Name
職員
202
Name
Twitter
@rocketpharma
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
RCKT's Discussions on Twitter

Compare RCKT vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
RCKT icon
RCKT
Rocket Pharmaceuticals Inc
3.91 457.52M 0 -209.38M -179.81M -1.8768
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
485.39 126.01B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
664.52 70.03B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
877.62 56.56B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
298.76 41.76B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
186.88 40.63B 742.00K -1.37B -1.07B -7.0731

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-18 ダウングレード JP Morgan Neutral → Underweight
2025-08-20 アップグレード BofA Securities Neutral → Buy
2025-07-25 ダウングレード BofA Securities Buy → Neutral
2025-05-30 ダウングレード Evercore ISI Outperform → In-line
2025-05-28 ダウングレード Goldman Neutral → Sell
2025-05-28 ダウングレード JP Morgan Overweight → Neutral
2025-05-28 ダウングレード Jefferies Buy → Hold
2025-05-28 ダウングレード Leerink Partners Outperform → Market Perform
2025-05-28 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-05-27 ダウングレード Needham Buy → Hold
2025-05-27 ダウングレード TD Cowen Buy → Hold
2025-03-12 開始されました BMO Capital Markets Outperform
2024-12-30 開始されました Wedbush Outperform
2024-12-18 開始されました Jefferies Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-04-02 開始されました Goldman Neutral
2023-10-24 開始されました Cantor Fitzgerald Overweight
2023-02-01 開始されました Morgan Stanley Overweight
2022-11-08 開始されました Canaccord Genuity Buy
2022-11-01 開始されました BTIG Research Buy
2022-07-08 開始されました Raymond James Outperform
2021-10-20 再開されました Cowen Outperform
2021-03-02 開始されました Stifel Buy
2021-02-18 開始されました Needham Buy
2020-12-16 開始されました UBS Buy
2020-12-08 ダウングレード Oppenheimer Outperform → Perform
2020-07-02 開始されました JP Morgan Overweight
2020-06-25 再開されました BofA/Merrill Buy
2020-06-01 再開されました Oppenheimer Outperform
2019-11-06 開始されました Chardan Capital Markets Buy
2019-09-26 開始されました Piper Jaffray Overweight
2019-04-23 開始されました Robert W. Baird Outperform
2019-03-15 開始されました BofA/Merrill Buy
2019-02-05 開始されました Oppenheimer Outperform
2018-09-13 開始されました Ladenburg Thalmann Buy
2018-07-10 開始されました William Blair Outperform
すべてを表示

Rocket Pharmaceuticals Inc (RCKT) 最新ニュース

pulisher
Jul 08, 2026

RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - Stocktwits

Jul 08, 2026
pulisher
Jul 08, 2026

Rocket Pharmaceuticals (RCKT) accounting chief reports 52,576-share RSU stake - Stock Titan

Jul 08, 2026
pulisher
Jul 08, 2026

Price to earnings forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKTW - TradingView

Jul 08, 2026
pulisher
Jul 07, 2026

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - AOL.com

Jul 07, 2026
pulisher
Jul 07, 2026

Form 144 ROCKET PHARMACEUTICALS For: 7 July By Investing.com - Investing.com India

Jul 07, 2026
pulisher
Jul 07, 2026

[144] ROCKET PHARMACEUTICALS, INC. SEC Filing - Stock Titan

Jul 07, 2026
pulisher
Jul 06, 2026

Number of shareholders of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKTW - TradingView

Jul 06, 2026
pulisher
Jul 06, 2026

Director at Rocket Pharmaceuticals (RCKT) receives RSUs and stock options - Stock Titan

Jul 06, 2026
pulisher
Jul 06, 2026

Rocket Pharmaceuticals (RCKT) director receives new RSU and stock option awards - Stock Titan

Jul 06, 2026
pulisher
Jul 05, 2026

RCKT Stock Jumps Over 10% Premarket: FDA Approves Its First Gene Therapy For Rare Childhood Immune Disease - Stocktwits

Jul 05, 2026
pulisher
Jul 04, 2026

Securities Lawsuit Alert: Rocket Pharmaceuticals, Inc. (RCKT)Contact Levi & Korsinsky Before August 11, 2025 - The National Law Review

Jul 04, 2026
pulisher
Jul 02, 2026

Rocket Pharmaceuticals, Inc. Warrant 2023- on Rocket Pharmctc Financial Disclosures & SEC Filings - TradingView

Jul 02, 2026
pulisher
Jul 01, 2026

RCKT Q1 2026 Earnings: Slight EPS Miss as Pre-Revenue Biotech Advances PipelineHigh Estimate Range - dars.gov.et

Jul 01, 2026
pulisher
Jun 30, 2026

Rocket Pharmaceuticals Appoints Joseph Manhede as Principal Accounting Officer – SEC 8-K Filing June 2026 - Minichart

Jun 30, 2026
pulisher
Jun 30, 2026

Rocket Pharmaceuticals (NASDAQ: RCKT) appoints new Principal Accounting Officer - Stock Titan

Jun 30, 2026
pulisher
Jun 29, 2026

Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Join Class Action to Recover Losses from Rocket Pharmaceuticals - The National Law Review

Jun 28, 2026
pulisher
Jun 27, 2026

RCKT ALERT: Levi & Korsinsky Files Securities Fraud Class Action - The National Law Review

Jun 27, 2026
pulisher
Jun 27, 2026

Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi - The National Law Review

Jun 27, 2026
pulisher
Jun 27, 2026

Investors Urged to Contact Levi & Korsinsky for Information Befor - The National Law Review

Jun 27, 2026
pulisher
Jun 27, 2026

Rocket Pharmaceuticals, Inc. (RCKT) LawsuitInvestors Urged to Contact Levi & Korsinsky Before August 11, 2025 - The National Law Review

Jun 27, 2026
pulisher
Jun 27, 2026

TNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - Stocktwits

Jun 27, 2026
pulisher
Jun 27, 2026

Price to earnings forward of Rocket Pharmaceuticals, Inc. – BOATS:RCKTW - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to sales forward of Rocket Pharmaceuticals, Inc. – BOATS:RCKTW - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – BOATS:RCKTW - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

Rocket Pharma updates cash position after selling priority review voucher - MSN

Jun 26, 2026
pulisher
Jun 26, 2026

Price to sales forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Rocket Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:RCKT) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Rocket Pharmaceuticals, Inc. Actuals & Estimates (HAM:9IP1) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Rocket Pharmaceuticals, Inc. Actuals & Estimates (TRADEGATE:9IP1) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to sales forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

RCKT Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Enterprise value to EBITDA forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone? - Insider Monkey

Jun 25, 2026
pulisher
Jun 25, 2026

Price to book forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to earnings forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Enterprise value to EBIT forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView

Jun 24, 2026
pulisher
Jun 24, 2026

Price to book forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView

Jun 24, 2026
pulisher
Jun 24, 2026

Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView

Jun 24, 2026
pulisher
Jun 24, 2026

Rocket Pharmaceuticals Inc (RCKT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 24, 2026
pulisher
Jun 23, 2026

Rocket Pharmaceuticals Inc (RCKT) Institutional Confidence - TradingKey

Jun 23, 2026
pulisher
Jun 22, 2026

ROCKET PHARMACEUTICALS INC (RCKT) Stock Chart - ChartMill

Jun 22, 2026
pulisher
Jun 22, 2026

Rocket Pharmaceuticals analyst consensus stays supportive, shares trade near recent lows - AD HOC NEWS

Jun 22, 2026

Rocket Pharmaceuticals Inc (RCKT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$56.43
price down icon 2.64%
$115.61
price down icon 2.24%
$35.97
price down icon 2.28%
$68.27
price down icon 10.83%
ONC ONC
$298.70
price down icon 1.36%
$186.88
price down icon 2.22%
大文字化:     |  ボリューム (24 時間):